PG changes
Pick any two versions below to diff them.
- Price
- $161.57 → $167.67(+3.8%)
- Discount category
- Close to intrinsic value → Far above intrinsic value
- Recent events
- Oct 26, 2026: P&G sold $4.0 billion of US dollar notes due from 2031 to 2056, at rates from 5.125% to 5.900%. removed: On added: It closed the sale on October removed: 27, added: 30. On November 3, it removed: started an offer added: closed a sale of added: €3.25 billion of euro notes removed: of an amount not yet set. added: due from 2030 to 2046, at rates from 3.750% to 4.625%. Oct 22, 2026: P&G reported fiscal first-quarter 2027 results. Net sales rose 4% to $23.3 billion, and organic sales also rose 4%, with about 2% from volume and 1% from mix. Core EPS rose 1% to $2.00, against the guidance of a fall of 5% or more. Core gross margin fell 1.5 points, mostly because of higher commodity costs and product investments. P&G kept its fiscal 2027 guidance of 1% to 3% organic sales growth and core EPS of $6.89 to $7.11, and raised its all-in sales growth guidance to 2% to 4% because of Thorne. It now expects about $1.4 billion after tax of commodity, energy and transport cost headwinds, up from about $1 billion. Oct 13, 2026: At the annual meeting, shareholders elected all 12 director nominees and voted against three shareholder proposals, per preliminary results. The board declared a quarterly dividend of $1.0885 per share, payable on or after November 16, 2026. Oct 1, 2026: P&G completed its purchase of Thorne for $3.9 billion in cash. Thorne is part of the Personal Health Care business. Sep 24, 2026: P&G confirmed that it will discuss its fiscal first-quarter 2027 results on October 22, 2026. Aug 4, 2026: P&G agreed to buy Thorne, a maker of premium vitamins and supplements, for $3.8 billion in cash. Thorne will join the Health Care segment. P&G expects the purchase to close between October and December 2026, after regulatory approvals. Jul 29, 2026: P&G reported fiscal 2026 results. Net sales were $87.0 billion, organic sales grew 1%, and core EPS was $6.89. All of the organic growth came from price, and volume was flat. For fiscal 2027, P&G guided organic sales growth of 1% to 3% and core EPS of $6.89 to $7.11, and it expects first-quarter core EPS to fall 5% or more. Jul 29, 2026: P&G's board named CEO Shailesh Jejurikar as Chairman, effective August 1, 2026. He succeeds Jon Moeller, who retired from the board on July 31, 2026, and from the company on August 14, 2026. Apr 14, 2026: P&G raised its quarterly dividend by 3% to $1.0885 per share. This is its 70th annual dividend increase in a row. Jun 5, 2025: P&G announced a two-year restructuring plan to cut about 7,000 non-manufacturing jobs, about 6% of its total workforce, and to exit some brands and categories.